• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
  • Contact

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

The Galien Foundation Debuts 2019 Prix Galien USA Nominees in "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Medical Technology" Categories

Winners Will be Announced by Committee of Distinguished Scientific Leaders on October 24, 2019 at the Prix Galien USA Awards Ceremony in New York

(PRNewsfoto/The Galien Foundation)

News provided by

The Galien Foundation

Jul 15, 2019, 07:30 ET

Share this article

Share this article


NEW YORK, July 15, 2019 /PRNewswire/ -- The Galien Foundation today announced the 2019 Annual Prix Galien USA Award nominees. Counted among the global health innovation industry's most prized honors, the Prix Galien Award recognizes outstanding biomedical and medical technology product achievement that improves the human condition.

To qualify, each candidate must be U.S. Food and Drug Administration (FDA) approved for marketing within the last five years and demonstrate significant potential to advance human health worldwide. Sales data are not considered by the nominating committee in their award nominee selection; innovative science and health impact is paramount.

"We are blessed to live in a time of exciting scientific, medical and technological advances that promise a revolution in cures, treatments and tools for patients everywhere," said Dr. Sue Desmond-Hellmann, chair of the Prix Galien USA Awards Committee and CEO of the Bill & Melinda Gates Foundation. "The 2019 nominees demonstrate this incredible potential across multiple platforms and reflect the abundance of new science that underpins the Galien Foundation's mission to improve the human condition."

The Prix Galien USA 2019 nominees include products evaluated in the following categories: "Best Biotechnology Product," with 17 nominees; "Best Pharmaceutical Product" with 22 nominees; and "Best Medical Technology," 17 nominees. 

Nominees include the first FDA-approved drugs using RNA interference technology and targeted mutation gene therapy; the first of a new line of 'tissue agnostic' cancer-fighting drugs; an entirely new class of female contraceptives, designed for use in resource-limited settings; novel inhalation devices that enhance dosing accuracy against major chronic conditions like asthma and COPD; the first FDA-approved therapy for endometriosis pain in more than a decade; the first in a new class of anti-epileptic drugs and first prescription product derived from the cannabis plant; and the first prescription digital therapeutic to address the opioid abuse crisis through interactive engagement between patient and clinician.

Best Biotechnology Product (Nominees)

Aimovig® (erenumab-aooe)

Amgen Inc.

Andexxa®

Portola Pharmaceuticals, Inc.

Dupixent®

Regeneron & Sanofi

ELZONRIS®

Stemline Therapeutics, Inc.

Emgality®

Eli Lilly & Co.

GALAFOLD®

Amicus Therapeutics

Hemlibra®

Genentech, Inc.

LUXTURNA™ (voretigene neparvovec-rzyl)

Spark Therapeutics

ONPATTRO®

Alnylam Pharmaceuticals

OXERVATE™

Dompé Pharmaceuticals

Palynziq®

BioMarin Pharmaceutical Inc

Revcovi™

Leadiant Biosciences, Inc.

SHINGRIX

GlaxoSmithKline

TREMFYA®

Janssen Research & Development, LLC

TAKHZYRO®

Takeda Pharmaceutical Company Limited

TEGSEDI®

Akcea Therapeutics and Ionis Pharmaceuticals

ULTOMIRIS® (ravulizumab-cwvz)

Alexion Pharmaceuticals, Inc.

Best Pharmaceutical Product (Nominees)

ANNOVERA™

Population Council

DAURISMO™

Pfizer Inc.

EPIDIOLEX®

GW Pharmaceuticals plc/Greenwich Biosciences Inc.

ERLEADA®

Janssen Research & Development, LLC

Gamifant® (emapalumab-lzsg)

Sobi

INGREZZA® (valbenazine) capsules

Neurocrine Biosciences, Inc.

Jardiance®

Boehringer Ingelheim Pharmaceuticals, Inc.

LORBRENA®

Pfizer Inc.

LUMOXITI™

AstraZeneca PLC; Innate Pharma SA

LUTATHERA®

Advanced Accelerator Applications USA, Inc.

Moxidectin

Medicines Development for Global Health

ORILISSA®

AbbVie Inc.

Pifeltro™ and Delstrigo™

Merck & Co., Inc.

Prevymis™

Merck & Co., Inc.

RADICAVA®

Mitsubishi Tanabe Pharma America, Inc.

Rhopressa®

Aerie Pharmaceuticals, Inc.

TPOXX®

SIGA Technologies, Inc.

Vabomere

Melinta Therapeutics, Inc.

VITRAKVI®

Bayer

XTANDI®

Pfizer Inc. and Astellas Pharma

YUPELRI® (revefenacin) Inhalation Solution

Theravance Biopharma, Inc.

ZEJULA®

TESARO, a GSK Company

Best Medical Technology (Nominees)

rhPDGF-BB Technology*

*Augment® Injectable Bone Graft; Augment® Bone Graft; GEM® Growth-factor Enhanced Matrix; Regranex Gel

Lynch Biologics, LLC

AXIOS™ Stent and Electrocautery Enhanced Delivery System

Boston Scientific Corp., Inc.

CUSTOMFLEX® ARTIFICIALIRIS

Clinical Research Consultants, Inc. and HumanOptics AG

FreeStyle® Libre 14 Day Flash Glucose Monitoring System

Abbott

GentleWave® System

Sonendo

HeartLogic™ Heart Failure Diagnostic

Boston Scientific Corp., Inc.

Implantable System for Remodulin®

Medtronic plc

INSPIRIS RESILIA Aortic Valve™

Edwards Lifesciences Corporation

iStent inject®

Glaukos Corporation

Magtrace® and Sentimag® Magnetic Localization System

Endomag

Medtronic DBS Therapy for Epilepsy

Medtronic Brain Modulation

PK Papyrus Covered Coronary Stent System

BIOTRONIK

ProAir® Digihaler™

Teva Pharmaceutical Industries

reSET® and reSET-O®

Pear Therapeutics

Sentinel™ Cerebral Protection System

Boston Scientific Corp., Inc.

Starkey Livio® AI

Starkey Hearing Technologies

Zephyr Endobronchial Valve System

Pulmonx

"The nominees selected by our independent committee reflect how drug, device and delivery technologies are converging to offer more options for people, especially those with untreatable conditions, along with the ability to make products more effective and convenient for those who need them most, including for the aged, children and women," said Bruno Cohen, Chairman of the Galien Foundation.  "In addition to all the great science, it reflects progress in the global movement for health equity, which is also central to our mission to improve the human condition.  Thus, it is both timely and proper that our gathering on October 24 will celebrate the achievements of these researchers and innovators, whose work represents the next chapter of human progress in fighting disease."

The Prix Galien USA Committee is composed of 12 renowned leaders from the biomedical industry and academia, including four Nobel Laureates, who together are responsible for evaluating nominees. Winners will be announced during the Prix Galien USA Awards Ceremony on October 24, 2019 at the American Museum of Natural History in New York City.  Registration to attend the 2019 Prix Galien Awards Ceremony can be accessed at http://register.prix-galien-usa.com

Prix Galien Awards Committee 2019

Susan DESMOND-HELLMANN, M.D., M.P.H, Chief Executive Officer of the Bill & Melinda Gates Foundation; Committee Chair

Richard AXEL, M.D., Nobel Laureate, Co-Director, Kavli Institute for Brain Science, Columba University Medical Center, NYC, NY 

Michael S. BROWN, M.D., Nobel Laureate, Professor of Molecular Genetics and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX

Laurie GLIMCHER, M.D., CEO and President, Dana Farber Cancer Institute, Professor of Medicine, Harvard Medical School, Cambridge, MA

Joseph GOLDSTEIN, M.D., Nobel Laureate, Professor of Molecular Genetics and Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, TX

Robert LANGER, Sc.D., David H. Koch Institute Professor, MIT, Cambridge, MA

Cato T. LAURENCIN, M.D., PhD., University Professor, University of Connecticut, Storrs, CT

Paul A. MARKS, M.D., Laboratory Head of Cell Biology and President Emeritus, Memorial Sloan Kettering Cancer Center, NYC, NY

Michael ROSENBLATT, M.D., Chief Medical Officer, Flagship Pioneering Inc, Cambridge, MA

Bengt SAMUELSSON, M.D., Ph.D., Nobel Laureate, Former President, Karolinska Institute; Former Chairman, Nobel Foundation 

Marc TESSIER-LAVIGNE, Ph.D., President, Stanford University, Palo Alto, CA

P. Roy VAGELOS, M.D., Retired Chairman and CEO, Merck & Co.; Chairman of the Board, Regeneron Pharmaceuticals, Inc.; Committee Chairman (2012-2017)

About the Galien Foundation

The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to catalyze the development of the next generation of innovative treatments and technologies that will impact human health and save lives.

The Foundation oversees and directs activities in the USA for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies.  The Prix Galien was created in France in 1970 in honor of Galen, the father of medical science and modern pharmacology.  Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical and medical technology research.

For more information, visit www.galienfoundatinon.org

Galien Foundation Media Contact:
Kara Bradley
Finn Partners
646 213 7243
[email protected]

SOURCE The Galien Foundation

Modal title

Also from this source

The Galien Foundation Appoints Michael Rosenblatt, M.D., as Chairman of Prix Galien USA Awards Committee

The Galien Foundation Appoints Michael Rosenblatt, M.D., as Chairman of Prix Galien USA Awards Committee


The Galien Foundation Honors 2022 Prix Galien Award Recipients

The Galien Foundation Honors 2022 Prix Galien Award Recipients

Explore

More news releases in similar topics

  • Health Care & Hospitals
  • Pharmaceuticals
  • Medical Pharmaceuticals
  • Awards

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2023 Cision US Inc.